When antibiotics disrupt infant brains: the hidden role of the microbiota
AI-generated hypothesis · Pre-publication · To be tested experimentally
Table of contents — full brief
- Hypothesis and mechanismCausal chain, key assumptions, residual unknowns
- State of the artVerified references and counter-evidence (DOIs)
- Falsifiable predictionsQuantitative bounds, statistical tests, H0
- Experimental protocolThree phases — in silico → minimal → full
- Impact analysisNovelty, residual gaps, available data
- Panel reviewFive personas + meta-review
Verified references
5 of 11 references- DOI: 10.1038/s41583-021-00507-y ↗
Mechanisms governing activity-dependent synaptic pruning in the mammalian CNS
2021 - DOI: 10.1002/glia.24343 ↗
Interactions of glial cells with neuronal synapses, from astrocytes to microglia and oligodendrocyte lineage cells
2023 - DOI: 10.3389/fncel.2017.00025 ↗
Gut Microbiota: A Potential Regulator of Neurodevelopment
2017 - DOI: 10.1186/s40168-023-01656-1 ↗
Microbiota-indole 3-propionic acid-brain axis mediates abnormal synaptic pruning of hippocampal microglia and susceptibility to ASD in IUGR offspring
2023 - DOI: 10.1002/jnr.24616 ↗
Dysregulation of synaptic pruning as a possible link between intestinal microbiota dysbiosis and neuropsychiatric disorders
2020
+ 6 more references
Detailed panel scores
The protocol comprises a phased approach with in silico validation prior to experimental investment, which constitutes a rigorous and economically efficient strategy for refining predictions and assessing plausibility.
The hypothesis integrates established knowledge on microglia-mediated synaptic pruning with emerging data on gut–brain axis signalling, proposing a plausible mechanistic link via SCFAs and FFAR2 receptors.
The hypothesis addresses a topical and important question concerning the gut–brain axis in neurodevelopment, with potential implications for the understanding of psychiatric disorders.
Potential market in paediatric neurodevelopmental disorders (autism, ADHD) and antimicrobial stewardship programmes; addressable market estimated at USD 2 billion by 2030 for microbiome-based interventions.
The hypothesis is highly innovative, establishing a bridge between microbiome research and neurodevelopmental mechanisms, a domain of growing priority for major funding agencies.
Receive the next SPORE hypotheses
Once or twice a month, in your inbox. No spam, one-click unsubscribe.
Your data stays private. No third-party sharing. GDPR-compliant.